Brands — Net Sales
Viatris Brands — Net Sales decreased by 0.6% to $2.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.2%, from $2.12B to $2.33B. Over 4 years (FY 2021 to FY 2025), Brands — Net Sales shows a downward trend with a -4.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful lifecycle management or pricing power, while a decrease may indicate patent cliffs, increased generic competition, or declining market share.
Detailed definition
This metric represents the total revenue generated from the sale of branded pharmaceutical products within the company's...
Peer comparison
Peers in the pharmaceutical industry report this as 'Branded Revenue' or 'Established Products Revenue', typically benchmarked against total segment revenue growth rates.
vtrs_segment_brands_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.70B | $2.80B | $2.61B | $2.55B | $2.48B | $2.54B | $2.31B | $2.42B | $2.44B | $2.53B | $2.40B | $2.31B | $2.36B | $2.36B | $2.17B | $2.12B | $2.28B | $2.44B | $2.35B | $2.33B |
| QoQ Change | — | +3.8% | -6.8% | -2.2% | -2.8% | +2.3% | -9.0% | +4.7% | +1.0% | +3.6% | -5.2% | -3.9% | +2.3% | -0.0% | -8.3% | -2.3% | +7.9% | +6.7% | -3.7% | -0.6% |
| YoY Change | — | — | — | — | -8.1% | -9.4% | -11.5% | -5.2% | -1.5% | -0.3% | +3.9% | -4.6% | -3.3% | -6.7% | -9.8% | -8.3% | -3.3% | +3.2% | +8.3% | +10.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Viatris's brands — net sales?
- Viatris (VTRS) reported brands — net sales of $2.33B in Q1 2026.
- How has Viatris's brands — net sales changed year-over-year?
- Viatris's brands — net sales increased by 10.2% year-over-year, from $2.12B to $2.33B.
- What is the long-term trend for Viatris's brands — net sales?
- Over 4 years (2021 to 2025), Viatris's brands — net sales has grown at a -4.1% compound annual growth rate (CAGR), from $10.84B to $9.18B.
- What does brands — net sales mean?
- The total revenue earned from selling branded pharmaceutical products.